Strategy and TPP

Recent Posts

• Building a Stronger Path to Market Through Early Clinical Research Strategy
• Why Early Clinical Research Strategy Is Critical to Successful Drug Development
• Why Rare Disease Drug Development Requires a Different Clinical Strategy
• Why do orphan drug launches require specialized strategic planning?
• BBCR and its consultants are dedicated to advancing innovative and repurposed treatments for orphan diseases, an area where impact is high, but the path is complex.